Search

Search Constraints

You searched for: Author/Creator Schuster, Heiko

Search Results

1. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. Issue 1 (15th November 2019)

3. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer. Issue 4 (1st May 2016)

4. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer. Issue 4 (May 2016)

5. Front Cover: Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection. Issue 12 (27th June 2018)

6. HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. (4th March 2017)

7. HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. (3rd April 2018)

8. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. (3rd May 2016)

9. The SysteMHC Atlas project. Issue Volume 46:Issue D1(2018) (29th July 2017)

10. Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection. Issue 12 (10th April 2018)